[Antibiotic prophylaxis of infective endocarditis in dental procedures: challenges, certainties, and perspectives].
Antibiotic prophylaxis against infective endocarditis (IE) before dental procedures is currently limited to high-risk patients, yet there is no evidence of its efficacy/inefficacy in humans, and it is unlikely there will be for organizational and economic reasons. Most cases of endocarditis from oral streptococci are due to bacteremias associated with chewing and oral hygiene habits, which could be reduced by regular oral hygiene. Data from studies conducted after the most recent guidelines are not sufficient to establish a relationship between the reduction in patient groups to which antibiotic prophylaxis is given and the incidence trend of endocarditis from oral streptococci. This is mainly attributed to study limitations and lack of data on physicians' adherence to official recommendations. Patients at risk of IE should be made aware of the lack of firm evidence of the benefits of antibiotic prophylaxis for IE in humans and be involved in the decision to receive it or not. According to some studies, the administration of aspirin and ticlopidine to experimental animals followed by the induction of low-grade bacteremia has prevented IE in most cases. However, the possible use of these drugs in humans requires further clinical studies.